Page 39 - Pharma

ICMR's biomedical research centre in Hyderabad receives Cabinet nod

National Resource Facility for Bio-medical Research (NARF) will be built with an investment of Rs 338 cr by the Indian Council for Medical Research (ICMR)

IOL Chemicals raises ibuprofen capacity to 6200 tpa

Expansion follows a de-bottlenecking project undertaken by the company at an estimated cost of Rs 24 crores

Take Solutions buys Ecron Acunova to expand into biosimilars space

The acquisition of Ecron Acunova will enable Take Solutions to add expertise in the areas of biosimilars, regenerative medicine and diagnostic imaging agents segments

Zydus to begin phase 2 clinical trials for saroglitazar in US

The company will begin phase 2 clinical trial of saroglitazar, which is already marketed in India as Lipaglyn, in patients with severe hypertriglyceridemia in the US

Dr Reddy's buys fondaparinux IP rights from Australia's Alchemia

As per the agreement, Dr Reddy's Labs gets the worldwide exclusive intellectual property rights for fondaparinux sodium, a generic version of the anticoagulant drug Arixtra

France's Air Liquide buys US-based Airgas for $13.4 bn

Integration of these two businesses will led to creation of the largest industrial gases company in the world

Govt to open AMRIT pharmacy to sell low-cost cancer & heart drugs

First Affordable Medicines and Reliable Implants for Treatment (AMRIT) outlet launched at AIIMs in New Delhi to sell drugs for the two ailments at highly discounted rates

Global orphan drug sales to reach $ 178 bn by 2020

Median cost per patient is 13.8 times higher for orphan drugs compared to non-orphan, states EvaluatePharma report

Roche to shut down 4 facilities to restructure production capabilities

The company will also invest CHF 300 million to strengthen development and launch capabilities for specialised medicines at Kaiseraugst, Switzerland

Ajanta Pharma launches asthma drug montelukast

The approval and launch of the montelukast granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market

Future of branded drugs in a generic world

With many of the bestselling patented brands approaching patent expiration, pharma companies are looking at various strategies to 'save' their brands

Shasun Pharma receives FDA approval for pain relief drug Carisoprodol

Carisoprodol tablets (250 mg and 350 mg) have sales of approximately $38 million

Canada's Fairfax acquires 45% stake in ADI Finechem for Rs 130 cr

Fairfax India will also make an open offer for an additional 26% stake in ADI Finechem, a speciality chemical manufacturer located near Ahmedabad (Gujarat)

Bosch inks collaboration pact with PSG Institute

Two sides will jointly work on focussed topics in the area of healthcare, energy and mobility

Dr Reddy's to market Biocodex products in Romania

French specialty pharmaceutical company Biocodex has given Dr Reddy's the complete rights to promote and distribute its products across Romania

Lupin appoints Thierry Volle as EMEA president

Thierry Volle will be responsible for the company's growth and development in Europe, Russia & CIS, and Middle-east and African markets

NIPER inks MoUs with pharma companies to boost innovation

The Department of Pharmaceuticals is drawing up a common road map for drug discovery through convergence and synergy involving all stakeholders

Torrent Pharma commissions Dahej plant

The company has invested over Rs 650 crore in the first phase of the facility, which is the company's fifth formulation plant and the second APIs plant

Dr Reddy's receives US FDA warning letter for AP and TN facilities

The company says that it will respond with a comprehensive plan to address the observations, mentioned in the letter, within the stipulated time-frame of 15 days

Aarti Industries to demerge pharma and home & personal care businesses

Meanwhile, the company has commissioned its expanded nitro chloro benzene (NCB) facility having production capacity of 75,000 metric tonnes